Glenmark Pharma on Thursday announced that its pharmaceutical company has received the final nod from the US Health Regulators (USFDA) for its Clindamycin Phosphate Gel which is used for the treatment of acne.
Clindamycin Phosphate Gel is a generic version of Cleocin T Gel 1% of Pharmacia & Upjohn. In a regulatory filling, Glenmark said that Cleocin T Gel 1% received 73.8 million in annual sales in the US for 12 month period which ended in Dec 2020.
Glenmark currently has 169 products which have received full authorization for distribution in the US market while 42 new applications for the drug are still pending from USFDA.